DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB16077
| null |
Abagovomab
|
792921-10-9
|
3YK0326U7X
|
Abagovomab
| null |
DB16078
| null |
Abeprazan
|
1902954-60-2
|
BE52S2C1QT
| null |
OUNXGNDVWVPCOL-UHFFFAOYSA-N
|
DB16079
| null |
Aclimostat
|
2082752-83-6
|
X150A3JK8R
|
Aclimostat
|
QJWJPMLDQYEPPW-AUKZVGPFSA-N
|
DB16080
| null |
Acolbifene
|
182167-02-8
|
815LJ9X0D1
|
Acolbifene
|
DUYNJNWVGIWJRI-LJAQVGFWSA-N
|
DB16081
| null |
Acrizanib
|
1229453-99-9
|
F2CB8801I3
|
Acrizanib
|
XPIHPLVWOUDMPF-UHFFFAOYSA-N
|
DB16082
| null |
Adagloxad simolenin
|
1458687-85-8
|
UCG949AA7Z
|
Adagloxad simolenin
| null |
DB16083
| null |
Adelmidrol
|
1675-66-7
|
1BUC3685QU
|
Adelmidrol
|
PAHZPHDAJQIETD-UHFFFAOYSA-N
|
DB16084
| null |
Iron (III) oxide adipate
|
764-65-8
|
U3YC62H084
|
Adipate | Adipate dianion | Adipate ion | Adipate(2-) | Adipic acid ion (2-) | Hexanedioate dianion | Hexanedioic acid, ion(2-)
|
WNLRTRBMVRJNCN-UHFFFAOYSA-L
|
DB16085
| null |
Aganepag isopropyl
|
910562-20-8
|
R096XE6760
|
Aganepag isopropyl
|
GKRBCKDGBDUAIQ-URXFXBBRSA-N
|
DB16086
| null |
Aldafermin
|
1616639-03-2
|
IK9NYN31ZM
|
(phe5>met,ser6>arg,ala8>ser,gly9>ser,his11>leu) fibroblast growth factor 19 (human fgf19) (5-194)-peptide, produced in escherichia coli | Aldafermin | Engineered variant of recombinant human fibroblast growth factor 19
| null |
DB16087
| null |
Alflutinib
|
1869057-83-9
|
A49A7A5YN4
| null |
GHKOONMJXNWOIW-UHFFFAOYSA-N
|
DB16088
| null |
Amtolmetin guacil
|
87344-05-6
|
3RS348SV6U
|
Amtolmetin | Tolmetin glycine amide
|
IYNXNYQOVKPFMM-UHFFFAOYSA-N
|
DB16089
| null |
Anivamersen
|
959716-29-1
|
4OXU6KPQ3R
|
Anivamersen | Rna, (cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm)
| null |
DB16090
| null |
CX-2009
|
2145115-85-9
|
RD2I59M9FC
|
Anti-cd166 probody-drug conjugate cx-2009 | Praluzatamab ravtansine
| null |
DB16091
| null |
EMB-01
| null |
G86X5QQ7M5
|
Anti-egfr/anti-c-met bispecific antibody emb-01 | Anti-egfr/c-met bispecific antibody emb-01
| null |
DB16092
| null |
Simlukafusp alfa
|
1776942-10-9
|
FL08SGO9XA
|
Anti-fap/interleukin-2 fusion protein ro6874281 | RO6874281
| null |
DB16093
| null |
PEGylated Recombinant Factor VIII
|
1417412-83-9
|
5X3GF74R79
|
Adynovate | Adynovi | Antihemophilic factor (recombinant), pegylated (20 kda) | Antihemophilic factor (recombinant), pegylated (mw 20000) | Antihemophilic factor, pegylated (mw 20000) human sequence recombinant | PEGylated Recombinant Factor VIII | Pegylated rfviii
| null |
DB16094
| null |
Antithrombin gamma
|
1311281-25-0
|
29Y3UO9LWK
|
Acoalan | Afucosylated antithrombin | Antithrombin (human variant kw-3357) | Antithrombin gamma | Antithrombin gamma (genetical recombination) | Human antithrombin-iii (atiii, serpin c1) expressed in fucosyl transferase-negative chinese hamster ovary (cho) cells (glycoform gamma)
| null |
DB16095
| null |
APG-1387
|
1570231-89-8
|
E53VN70K2X
|
Apg-1387 (smac mimetic)
|
AKLBERUGKZNEJY-RTEPGWBGSA-N
|
DB16096
| null |
Apitegromab
|
2278276-46-1
|
UZ54216N0Y
|
Apitegromab | Immunoglobulin g4 (234-proline), anti-(human progrowth differentiation factor 8) (human monoclonal srk-015 .gamma.4-chain), disulfide with human monoclonal srk-015 .lambda.-chain, dimer
| null |
DB16097
| null |
Artemisone
|
255730-18-8
|
796LMW5BUZ
|
Artemifone | Artemisone
|
FDMUNKXWYMSZIR-NQWKWHCYSA-N
|
DB16098
| null |
Atogepant
|
1374248-81-3
|
7CRV8RR151
|
Atogepant
|
QIVUCLWGARAQIO-OLIXTKCUSA-N
|
DB16099
| null |
Avalglucosidase alfa
|
1802558-87-7
|
EO144CP0X9
|
Avalglucosidase alfa | avalglucosidase alfa-ngpt | Neo-recombinant human acid alpha-glucosidase | NeoGAA
| null |
DB16100
| null |
Axomadol
|
187219-99-4
|
9J92U4CVS0
|
Axomadol | Bn-110 free base | Bn110 free base | Grt-151 free base | Grt151 free base
|
LQJLLAOISDVBJM-OFQRWUPVSA-N
|
DB16101
| null |
Baicalein
|
491-67-8
|
49QAH60606
|
Noroxylin
|
FXNFHKRTJBSTCS-UHFFFAOYSA-N
|
DB16102
| null |
Bakuchiol
|
10309-37-2
|
OT12HJU3AR
|
(+)-bakuchiol | (s)-bakuchiol | Drupanol | Sytenol a
|
LFYJSSARVMHQJB-QIXNEVBVSA-N
|
DB16103
| null |
Batabulin
|
195533-53-0
|
T4NP8G3K6Q
|
Batabulin
|
ROZCIVXTLACYNY-UHFFFAOYSA-N
|
DB16104
| null |
Batoclimab
|
2187430-05-1
|
C98V9UMX3D
|
Batoclimab | Immunoglobulin g1(238-alanine, 239-alanine), anti-(human fcrn receptor) (human monoclonal hl161bkn .gamma.1-chain), disulfide with human monoclonal hl161bkn .lambda.-chain, dimer
| null |
DB16105
| null |
Bemarituzumab
|
1952272-74-0
|
RJW23BQ0KW
|
Anti-fgfr2 monoclonal antibody fpa144 | Bemarituzumab
| null |
DB16106
| null |
GSK2256098
|
1224887-10-8
|
R7O0O4110G
| null |
BVAHPPKGOOJSPU-UHFFFAOYSA-N
|
DB16107
| null |
BI 2536
|
755038-02-9
|
4LJG22T9C6
| null |
XQVVPGYIWAGRNI-JOCHJYFZSA-N
|
DB16108
| null |
TAK-715
|
303162-79-0
|
WE92U03C5Z
| null |
HEKAIDKUDLCBRU-UHFFFAOYSA-N
|
DB16109
| null |
GED-0507-34-Levo
|
921195-93-9
|
Y4H78S56YZ
| null |
QLJYLJGYIDIJPT-VIFPVBQESA-N
|
DB16110
| null |
GSK232802
|
843661-24-5
|
AG92SGO434
| null |
KNQLNDPHLXIOCY-UHFFFAOYSA-N
|
DB16111
| null |
CR6086
|
1417742-86-9
|
TNK4EB6VB5
| null |
CADWTPLFEZSAHM-UHFFFAOYSA-N
|
DB16112
| null |
OT-730
|
870809-51-1
|
5WVS67PLAL
| null |
ANXXSWNMHQHOQC-DJNXLDHESA-N
|
DB16113
| null |
Bizalimogene ralaplasmid
|
1977488-08-6
|
D8W2DVO5ZJ
|
Bizalimogene ralaplasmid
| null |
DB16114
| null |
HIV Integrase Inhibitor
|
729607-74-3
|
7PR4P7YOKT
|
BMS 707035
|
VNIWZCGZPBJWBI-UHFFFAOYSA-N
|
DB16115
| null |
Brazikumab
|
1610353-18-8
|
50EI9G8Q6U
|
Brazikumab | Immunoglobulin g2, anti-(human interleukin 23) (human monoclonal medi2070 heavy chain), disulfide with human monoclonal medi2070 .lambda.-chain, dimer
| null |
DB16116
| null |
Brivoligide
|
1803075-42-4
|
O32A9ET2M7
|
Brivoligide | D(c-t-a-c-g-c-c-c-a-c-c-g-c-c-c-a-c-g-c-a-t-a-c), complex with dna d(g-t-a-t-g-c-g-t-g-g-g-c-g-g-t-g-g-g-c-g-t-a-g) (1:1) | Dna, d(c-t-a-c-g-c-c-c-a-c-c-g-c-c-c-a-c-g-c-a-t-a-c), complex with dna d(g-t-a-t-g-c-g-t-g-g-g-c-g-g-t-g-g-g-c-g-t-a-g) (1:1)
| null |
DB16117
| null |
Buprenorphine hemiadipate
|
951123-45-8
|
968KUA5J54
|
Buprenorphine adipate ester
|
CVIJJOARNCQGON-XYQNZYJMSA-N
|
DB16118
| null |
Capadenoson
|
544417-40-5
|
O519NVW73R
|
Capadenoson
|
CITWCLNVRIKQAF-UHFFFAOYSA-N
|
DB16119
| null |
Carotegrast methyl
|
401905-67-7
|
OYK17DYO9M
|
Carotegrast methyl
|
MMHHPKCJJIFLBQ-QFIPXVFZSA-N
|
DB16120
| null |
Epigallo Catechin Gallate
|
25615-05-8
|
78OW2GLG8Q
|
(+)-catechin 3-gallate | (+)-catechin gallate | Catechin Gallate | Catechin gallate, (+)-
|
LSHVYAFMTMFKBA-PZJWPPBQSA-N
|
DB16121
| null |
Cemdisiran
|
1639264-46-2
|
S66Z65E10T
|
Cemdisiran
| null |
DB16122
| null |
Centhaquine
|
57961-90-7
|
QD4VI0J9T5
|
Centhaquine | Compound-7173
|
UJNWGFBJUHIJKK-UHFFFAOYSA-N
|
DB16123
| null |
Ceralifimod
|
891859-12-4
|
BZ2O8A84A4
|
Ceralifimod
|
QDDQIPUKAXBMBX-UHFFFAOYSA-N
|
DB16124
| null |
Chiauranib
|
1256349-48-0
|
F40IRN5981
| null |
BRKWREZNORONDU-UHFFFAOYSA-N
|
DB16125
| null |
Ciforadenant
|
1202402-40-1
|
8KFO2187CP
|
Ciforadenant
|
KURQKNMKCGYWRJ-HNNXBMFYSA-N
|
DB16126
| null |
Cinaciguat
|
329773-35-5
|
59K0Y58UAD
|
Cinaciguat
|
WPYWMXNXEZFMAK-UHFFFAOYSA-N
|
DB16127
| null |
Cinpanemab
|
2094516-02-4
|
W83JGQ40XX
|
Cinpanemab | Immunoglobulin g1-lambda, anti-(homo sapiens alpha-synuclein)humanized monoclonal antibody.gamma.1 heavy chain (1-442) (homo sapiens vh (ighv3-25*03 (86%) (ighd)-ighj2*01) (8.10.4) (1-113)-homo sapiens ighg1*03 (ch3(k107>del(443))) (114-442)) (216-213')- | Immunoglobulin g1-lambda, anti-(homo sapiens snca (synuclein alpha, alpha-synuclein, park1, park4, parkinson disease (autosomal dominant, lewy body) 4, non a4 component of amyloid precursor, nacp)), monoclonal antibodygamma1 heavy chain (1-442) (vh (homo | Immunoglobulin g1, anti-(human .alpha.-synuclein) (human monoclonal biib054 .gamma.1-chain), disulfide with human monoclonal biib054 .kappa.-chain, dimer
| null |
DB16128
| null |
Crovalimab
|
1917321-26-6
|
H9KH1GP3UU
|
Complement c5 inhibitory humanized recycling monoclonal antibody (rg-6107 ) | Crovalimab | IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS C5 (COMPLEMENT 5)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN (1-451) (VH (VICUGNA PACOS IGHV3S1*01 (70.4%)/HOMO SAPIENS IGHV3-66*01 (69.4%)-(IGHD)-HOMO SAPIENS IGHJ4*01 (100%)) (9.8.15) (1-123)-HOMO SAPIENS IGHG1* | Immunoglobulin g1, anti-(human complement c5)(humanized ro7112689 heavy chain), disulfide with humanized ro7112689 light chain, dimer
| null |
DB16129
| null |
TZP-102
|
1008993-65-4
|
9NFY3MS3SL
| null |
HIIMPSTXUQUYOO-KRANKMRJSA-N
|
DB16130
| null |
Dapansutrile
|
54863-37-5
|
2Z03364G96
|
Dapansutrile
|
LQFRYKBDZNPJSW-UHFFFAOYSA-N
|
DB16131
| null |
Dapirolizumab pegol
|
1416147-64-2
|
N4606MB5HM
|
Dapirolizumab pegol | Immunoglobulin fab' g1-kappa pegylated, anti-(homo sapiens cd40lg (cd40 ligand, cd40l, tumor necrosis factor ligand superfamily member 5, tnfsf5, tumor necrosis factor related activation protein, trap, cd154)), pegylated humanized monoclonal antibody
| null |
DB16132
| null |
Deferitrin
|
239101-33-8
|
T69Y9LDN44
|
Deferitrin
|
OEUUFNIKLCFNLN-LLVKDONJSA-N
|
DB16133
| null |
Delgocitinib
|
1263774-59-9
|
9L0Q8KK220
|
1,6-DIAZASPIRO(3.4)OCTANE-1-PROPANENITRILE, 3-METHYL-.BETA.-OXO-6-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-, (3S,4R)- | 3-[(3S,4R)-3-Methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile | Delgocitinib
|
LOWWYYZBZNSPDT-ZBEGNZNMSA-N
|
DB16134
| null |
Denagliptin
|
483369-58-0
|
DOS9ZOT21L
|
Denagliptin
|
URRAHSMDPCMOTH-LNLFQRSKSA-N
|
DB16135
| null |
Desidustat
|
1616690-16-4
|
Y962PQA4KS
|
Desidustat
|
IKRKQQLJYBAPQT-UHFFFAOYSA-N
|
DB16136
| null |
Dexisometheptene mucate
|
1620401-56-0
|
GOO8ZCK7RT
|
(R)-isometheptene | Dexisometheptene | Isometheptene, (r)-
|
XVQUOJBERHHONY-SECBINFHSA-N
|
DB16137
| null |
Dezapelisib
|
1262440-25-4
|
2K59L7G59M
|
6-(3-fluorophenyl)-3-methyl-7-[(1S)-1-(7H-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one | Dezapelisib
|
RSIWALKZYXPAGW-NSHDSACASA-N
|
DB16138
| null |
Diflomotecan
|
220997-97-7
|
QKT1LC4J1P
|
Diflomotecan
|
LFQCJSBXBZRMTN-OAQYLSRUSA-N
|
DB16139
| null |
DAR-0100A
|
174691-84-0
|
Q3PJ4B4D0X
|
Dihydrexidine, (+)-
|
BGOQGUHWXBGXJW-RHSMWYFYSA-N
|
DB16140
| null |
Dilpacimab
|
1791420-09-1
|
F27LAH6D5O
|
Dilpacimab | Immunoglobulin, anti-(notch ligand dll4/vascular endothelial growth factor) (synthetic human pr-1283233 heavy chain), disulfide with synthetic human pr-1283233 light chain, dimer
| null |
DB16141
| null |
Dimethandrolone Undecanoate
|
366472-45-9
|
VMT7Z23GLM
| null |
FVICENFBEMJOCE-RTFNQGFNSA-N
|
DB16142
| null |
Acetyldinaline
|
58338-59-3
|
RG9G4Z82PY
|
Dinalin | Dinaline
|
QGMGHALXLXKCBD-UHFFFAOYSA-N
|
DB16143
| null |
Dirocaftor
|
2137932-23-9
|
2G3T6M1AS9
|
Dirocaftor
|
TYQIFWXBQYAKCR-UHFFFAOYSA-N
|
DB16144
| null |
Dopastatin
|
868562-36-1
|
L32IM11DV4
| null |
WLBJBODHTIKYSL-RXHQQAJBSA-N
|
DB16145
| null |
Dotinurad
|
1285572-51-1
|
305EB53128
|
Dotinurad
|
VOFLAIHEELWYGO-UHFFFAOYSA-N
|
DB16146
| null |
Dynorphin
|
80448-90-4
|
9M18T0TD14
|
Dynorphin | Dynorphin a | Dynorphin a (1-17) | Dynorphin a (bos taurus) | Dynorphin a (human) | Dynorphin a (pig) | Dynorphin a (porcine) | Dynorphin a (rat) | Dynorphin a (swine) | Dynorphin a 1-17 | Dynorphins | Porcine dynorphin a (1-17)
|
JMNJYGMAUMANNW-FIXZTSJVSA-N
|
DB16147
| null |
Ebopiprant
|
2005486-31-5
|
Z1AVZ44TEJ
|
Ebopiprant
|
UUIBKACUTXYSAK-YCVJPRETSA-N
|
DB16148
| null |
Ecraprost
|
136892-64-3
|
Q2XM6VR8DO
|
Circulase | Ecraprost
|
HITYEEHTEOQBAC-OSIGYOHNSA-N
|
DB16149
| null |
Efavaleukin alfa
|
2049067-94-7
|
YNH9K62UXU
|
Efavaleukin alfa | Fc il-2 mutein fusion protein (amg-592) | Immunoglobulin g1 (fc domain-containing fragment) fusion protein with peptide (synthetic linker) fusion protein with interleukin 2 (synthetic human mutein), dimer
| null |
DB16150
| null |
Eftilagimod alfa
|
1800476-36-1
|
SJ82PK3HWA
|
Eftilagimod alfa | Immufact
| null |
DB16151
| null |
Efungumab
|
762260-74-2
|
BM86P708HW
|
Efungumab | Hsp-90mab | Hsp90mab | Immunoglobulin, anti-(candida heat-shock protein hsp 90) (human monoclonal hsp90mab fragment) | Mycograb
| null |
DB16152
| null |
VEGFR2-169
|
673478-49-4
|
S68632MB2G
|
Elpamotide | Vegfr2-169 peptide vaccine
|
ZAJHBCDPAUKEPU-GIKXZWSFSA-N
|
DB16153
| null |
Eltanexor
|
1642300-52-4
|
Q59IQJ9NTK
|
Eltanexor
|
JFBAVWVBLRIWHM-AWNIVKPZSA-N
|
DB16154
| null |
Eluforsen
|
2101868-82-8
|
V30WFP6S2Y
|
Eluforsen
| null |
DB16155
| null |
Empegfilgrastim
|
1192706-53-8
|
F0B69ZZ07A
|
Colony-stimulating factor, granulocyte (synthetic human), 30-kilodalton pegylated | Empegfilgrastim
| null |
DB16156
| null |
Enapotamab vedotin
|
1912424-97-5
|
43HH4XYH2N
|
Enapotamab vedotin | Humax axl adc | HuMax-AXL-ADC | Immunoglobulin g1, anti-(human growth factor receptor axl)(human humax-axl .gamma.1-chain), disulfide with human humax-axl .kappa.-chain, dimer tetrakis(thioether) with vedotin
| null |
DB16157
| null |
Ensifentrine
|
1884461-72-6
|
3E3D8T1GIX
|
2-(9,10-DIMETHOXY-4-OXO-2-(2,4,6-TRIMETHYLPHENYL)IMINO-6,7-DIHYDROPYRIMIDO(6,1-A)ISOQUINOLIN-3-YL)ETHYLUREA | Ensifentrine | N-(2-((2E)-9,10-DIMETOXI-4-OXO-2-((2,4,6-TRIMETILFENIL)IMINO)-6,7-DIHIDRO-2H-PIRIMIDO(6,1-A)ISOQUINOLEIN-3(4H)-IL)ETIL)UREA | UREA, N-(2-(6,7-DIHYDRO-9,10-DIMETHOXY-4-OXO-2-((2,4,6-TRIMETHYLPHENYL)IMINO)-2H-PYRIMIDO(6,1-A)ISOQUINOLIN-3(4H)-YL)ETHYL)-
|
CSOBIBXVIYAXFM-BYNJWEBRSA-N
|
DB16158
| null |
Epafipase
|
208576-22-1
|
369989188P
|
Epafipase | RPAF-AH
| null |
DB16159
| null |
Esflurbiprofen
|
51543-39-6
|
J5ZZK9P7MX
|
Esflurbiprofen | Flurbiprofen, (s)-
|
SYTBZMRGLBWNTM-JTQLQIEISA-N
|
DB16160
| null |
Tolinapant
|
1799328-86-1
|
2LHZ9ZC3YO
| null |
YCXOHEXZVKOGEV-DNRQZRRGSA-N
|
DB16161
| null |
Exebacase
|
1404122-92-4
|
67F0M5CY5Y
|
Des-met1-putative phage lysin (streptococcus phage phi891591), produced in escherichia coli | Exebacase | Lysin cf-301 (streptococcus suis phage) | Lysin plyss2 (streptococcus suis phage)
| null |
DB16162
| null |
Exicorilant
|
1781244-77-6
|
GTB859B7K8
|
Exicorilant
|
HWJYJKAURRIWJM-GKVSMKOHSA-N
|
DB16163
| null |
Fasoracetam
|
110958-19-5
|
42O8UF5CJB
|
Fasoracetam
|
GOWRRBABHQUJMX-MRVPVSSYSA-N
|
DB16164
| null |
Fenpyroximate
|
134098-61-6
|
9W557V4RYA
|
Fenpryroximate | Fenpyroximate (z,e) | Fujimite | Sequel
|
YYJNOYZRYGDPNH-MFKUBSTISA-N
|
DB16165
| null |
Finerenone
|
1050477-31-0
|
DE2O63YV8R
|
Finerenone
|
BTBHLEZXCOBLCY-QGZVFWFLSA-N
|
DB16166
| null |
Firsocostat
|
1434635-54-7
|
XE10NJQ95M
|
Firsocostat
|
ZZWWXIBKLBMSCS-FQEVSTJZSA-N
|
DB16167
| null |
Fisogatinib
|
1707289-21-1
|
5Q7R99CKV2
|
Fisogatinib
|
MGZKYOAQVGSSGC-DLBZAZTESA-N
|
DB16168
| null |
Fluorocyclopentenylcytosine
|
865838-26-2
|
0Z4A82I0JO
|
4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one | Fluorocyclopentenylcytosine | Roducitabine
|
QLLGKCJUPWYJON-HLTSFMKQSA-N
|
DB16169
| null |
Fonadelpar
|
515138-06-4
|
FK5ZAD810Z
|
Fonadelpar
|
WWKYLBGQYALEDL-UHFFFAOYSA-N
|
DB16170
| null |
Foralumab
|
946415-64-1
|
J43DL56H6M
|
Foralumab
| null |
DB16171
| null |
Foscarbidopa
|
1907685-81-7
|
5NT8HCA4OO
|
Foscarbidopa
|
PQUZXFMHVSMUNG-JTQLQIEISA-N
|
DB16172
| null |
Foslinanib
|
1256037-60-1
|
2X2DNM7NGX
|
Foslinanib | Trx-818 free acid
|
ZDWFMAHQGDEALT-UHFFFAOYSA-N
|
DB16173
| null |
Ganaplacide
|
1261113-96-5
|
85VMN9JU7A
|
2-Amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]ethanone | Ganaplacide
|
BUPRVECGWBHCQV-UHFFFAOYSA-N
|
DB16174
| null |
Giroctocogene fitelparvovec
|
2166101-71-7
|
C43ZSD4HNV
|
Aav2/6-b-domain-deleted blood coagulation factor viii | Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying) | Giroctocogene fitelparvovec | PF 07055480 | PF07055480
| null |
DB16175
| null |
Glenzocimab
|
2101829-58-5
|
58D9BCH9O0
|
Glenzocimab | Immunoglobulin g1, anti-(human platetet glycoprotein vi) fab fragment (humanized monoclonal act017 .gamma.1-chain), disulfide with humanized monoclonal act017 .kappa.-chain
| null |
DB16176
| null |
AIM-102
|
551936-17-5
|
3JX85UOO24
| null |
CNDMSQXUUIBFPE-VXGBXAGGSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.